Ascentage Pharma Group International - AAPG Future Profit

AAPG (Ascentage Pharma Group International) - company brandmark

Ascentage Pharma Group (AAPG) complies with medical regulations regarding the disposal of biomaterials. The development of cancer therapies relies on AI modeling and automated substance synthesis under physician supervision. High-tech robots accelerate the bioscreening of compounds. This forward earnings chart visualizes these processes, where 0.03 becomes the new metric value, helping to assess the asset's future cash flows.

AAPG: ascentage.com Future Profit 01/25/2025 - 11/28/2025

Ascentage - analytical breakdowns and key metrics (AAPG)

- price and consensus price forecast:
Fundamental company analysis:ascentage.com, AAPG
Core merchandise of Ascentage Pharma Group International

This indicator calculates the expected financial return through probability distributions of future cash flows, determining the fundamental value of the business based on projected revenues. Amid FDA pressure and the US-China trade confrontation, the risk of asset freezes for Ascentage Pharma Group (AAPG) directly impacts target profit metrics, where the stability of the curve may mask hidden opportunity costs.

Main competitors

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|CGON (CG Oncology Corp) - Expected Net Income|Projected Future Earnings URGN (urogen.com)|BCAX - Future Profit|PSNL: Future Profit|ERAS - Projected Future Earnings|Delcath (DCTH) - Expected Profit|YmAbs - Expected Net Income|AURA (Aura Biosciences Inc) - Projected Future Earnings|Expected Net Profit Candel Therapeutics CADL|Projected Future Earnings ARAY|SLS - Expected Net Profit|Projected Future Earnings ACTU (Actuate Therapeutics Inc)|Company Profit Forecast Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Projected Future Earnings|Expected Net Profit Protara Therapeutics, Inc.|FATE: Projected Future Earnings|WHWK - Company Profit Forecast|Expected Profit TScan Therapeutics, Inc.|Champions Oncology - Forward Earnings|Projected Future Earnings XBIT|Company Profit Forecast CEL-SCI Corp|Expected Profit OS Therapies OSTX|Expected Net Income RADX|artivabio.com - Projected Future Earnings|Expected Net Income ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Future Profit|TPST: Future Net Profit|XLO (Xilio) - Projected Future Earnings|renovarobio.com (RENB) - Company Profit Forecast|Expected Profit Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Expected Net Income|Projected Future Earnings OKUR (OnKure Therapeutics, Inc.)|Expected Net Income GDTC|Curis Inc. - Projected Future Earnings|APLM (apollomicsinc.com) - Net Profit Forecast|THAR: Projected Future Earnings|Expected Net Profit Advanced Biomed Inc. (ADVB)|Expected Profit Genprex, Inc|Projected Future Earnings calidibio.com|Expected Profit Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit